🇨🇦 rabeprazole-based triple therapy in Canada

rabeprazole-based triple therapy (rabeprazole-based triple therapy) regulatory status in Canada.

Marketing authorisation

rabeprazole-based triple therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is rabeprazole-based triple therapy approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for rabeprazole-based triple therapy in Canada?

Kaohsiung Medical University is the originator. The local marketing authorisation holder may differ — check the official source linked above.